JPM22, Day 2: Sanofi's dealmaking priorities, bluebird's gene therapy goals and more

The 40th annual J.P. Morgan Healthcare Conference rolls on today with virtual presentations and Q&A sessions from some of the biggest names in biopharma. Be sure to check in throughout the day to get the latest happenings from the virtual conference.

To look back at Fierce Pharma's coverage from Day 1, click here. And check out Fierce Biotech's coverage here.